As of December 15, 2025, CISO Global Inc (CISO) reports a Current Ratio of 0.14.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of CISO Global Inc's Current Ratio
Over recent years, CISO Global Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-12-31 | 0.14 |
| 2023-12-31 | 0.42 |
| 2022-12-31 | 0.62 |
| 2021-12-31 | 1.91 |
| 2020-12-31 | 1.64 |
This gradual decrease highlights how CISO Global Inc manages its short-term assets and liabilities over time.
Comparing CISO Global Inc's Current Ratio to Peers
To better understand CISO Global Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| CISO Global Inc (CISO) | 0.14 |
| MustGrow Biologics Corp (MGRO.CN) | 11.24 |
| Talis Biomedical Corp (TLIS) | 8.86 |
| Angion Biomedica Corp (ANGN) | 8.08 |
| Landos Biopharma Inc (LABP) | 6.09 |
| TAAL Distributed Information Technologies Inc (TAAL.CN) | 5.73 |
Compared to its competitors, CISO Global Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.